发明名称 |
Compositions and methods for visualizing and eliminating cancer stem cells |
摘要 |
The present invention relates generally to the field of cancer diagnosis and treatment, and more particularly to compositions and methods that may be useful for eliminating cancer cells with stem-like characteristics. The disclosed compositions and methods may also be useful for managing breast cancer, ovarian cancer, cervical cancer or endometrial (uterine) cancer with metastases; and visualizing the cancer cells in patient's body. The compositions of the instant invention include human prolactin receptor antagonist G129R. |
申请公布号 |
US8754035(B2) |
申请公布日期 |
2014.06.17 |
申请号 |
US201012706702 |
申请日期 |
2010.02.16 |
申请人 |
Oncolix, Inc. |
发明人 |
Chen Wen Y. |
分类号 |
A61K38/00;C07K7/06 |
主分类号 |
A61K38/00 |
代理机构 |
Morgan Lewis & Bockius LLP |
代理人 |
Morgan Lewis & Bockius LLP |
主权项 |
1. A method for inhibiting growth of cancer cells in a patient, comprising administering to the patient an effective amount of a human prolactin receptor antagonist comprising the sequence of SEQ ID NO: 4 in which a glycine residue at position 129 is substituted with another amino acid;
wherein the cancer cells do not express estrogen receptor, progesterone receptor and HER2/neu; and further wherein the cancer cells are selected from the group consisting of ovarian cancer cells, uterine (endometrial) cancer cells, cervical cancer cells and breast carcinoma cells.
|
地址 |
Houston TX US |